Literature DB >> 6871871

Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure.

W D Kerns, K L Pavkov, D J Donofrio, E J Gralla, J A Swenberg.   

Abstract

Groups of approximately 120 male and 120 female Fischer 344 rats and C57BL/6 X C3H F1 mice were exposed by inhalation to 0, 2.0, 5.6, and 14.3 ppm of formaldehyde gas 6 hr/day, 5 days/week, for 24 months. This exposure period was followed by up to 6 months of nonexposure. Interim sacrifices were conducted at 6, 12, 18, 24, 27, and 30 months. Significant formaldehyde-induced lesions were restricted to the nasal cavity and proximal trachea. The distribution and severity of these lesions were concentration dependent. Rhinitis, epithelial dysplasia, and squamous metaplasia occurred in all exposure groups of rats and in the intermediate and high exposure groups of mice. There was regression of rhinitis, dysplasia, and metaplasia at 27 months (3 months postexposure) in the 14.3- and 5.6-ppm groups of mice and in the 2.0- and 5.6-ppm groups of rats. Squamous cell carcinomas were observed in the nasal cavities of 103 rats (52 females and 51 males) and 2 male mice exposed to 14.3 ppm and in 2 rats (one male and one female) exposed to 5.6 ppm of formaldehyde gas. Formaldehyde inhalation was also weakly associated with an increase in the frequency of polypoid adenomas in the nasal cavity of male rats.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871871

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  84 in total

1.  Identifying an indoor air exposure limit for formaldehyde considering both irritation and cancer hazards.

Authors:  Robert Golden
Journal:  Crit Rev Toxicol       Date:  2011-06-02       Impact factor: 5.635

2.  Is exposure to formaldehyde in air causally associated with leukemia?--A hypothesis-based weight-of-evidence analysis.

Authors:  Lorenz R Rhomberg; Lisa A Bailey; Julie E Goodman; Ali K Hamade; David Mayfield
Journal:  Crit Rev Toxicol       Date:  2011-06-02       Impact factor: 5.635

3.  A case-control study of occupational risk factors for laryngeal cancer.

Authors:  P Wortley; T L Vaughan; S Davis; M S Morgan; D B Thomas
Journal:  Br J Ind Med       Date:  1992-12

Review 4.  [For expert evaluation of a possible connection: formaldehyde and nasopharyngeal cancer].

Authors:  O Michel
Journal:  HNO       Date:  2016-02       Impact factor: 1.284

Review 5.  DNA-protein crosslinks from environmental exposure: Mechanisms of formation and repair.

Authors:  Yusuke Kojima; Yuichi J Machida
Journal:  Environ Mol Mutagen       Date:  2020-07-09       Impact factor: 3.216

6.  Structural characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides and their oligomers.

Authors:  Kun Lu; Wenjie Ye; Li Zhou; Leonard B Collins; Xian Chen; Avram Gold; Louise M Ball; James A Swenberg
Journal:  J Am Chem Soc       Date:  2010-03-17       Impact factor: 15.419

7.  Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia.

Authors:  Kun Lu; Leonard B Collins; Hongyu Ru; Edilberto Bermudez; James A Swenberg
Journal:  Toxicol Sci       Date:  2010-02-22       Impact factor: 4.849

8.  Formation of S-[1-(N2-deoxyguanosinyl)methyl]glutathione between glutathione and DNA induced by formaldehyde.

Authors:  Kun Lu; Wenjie Ye; Avram Gold; Louise M Ball; James A Swenberg
Journal:  J Am Chem Soc       Date:  2009-03-18       Impact factor: 15.419

9.  Formaldehyde and cancer morbidity among male employees in Denmark.

Authors:  J Hansen; J H Olsen
Journal:  Cancer Causes Control       Date:  1995-07       Impact factor: 2.506

10.  Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: identification of key issues.

Authors:  Ravi P Subramaniam; Chao Chen; Kenny S Crump; Danielle Devoney; John F Fox; Christopher J Portier; Paul M Schlosser; Chad M Thompson; Paul White
Journal:  Risk Anal       Date:  2008-06-28       Impact factor: 4.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.